LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
2291.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.72B
Close$
$22.06
61.6% upside
Current Fair Value
61.6% upsideUndervalued by 61.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.72 Billion |
|---|---|
| Enterprise Value | $3.49 Billion |
| Dividend Yield | $0.57 (4.21%) |
| Earnings per Share | $0.69 |
| Beta | -0.2 |
| Outstanding Shares | 346,729,000 |
Return
| Return on Equity | 24.44% |
|---|---|
| Return on Assets | 21.82% |
| Return on Invested Capital | 27.77% |
Valuation & Multiples
| P/E Ratio | 19.62 |
|---|---|
| PEG | -95.24 |
| Price to Sales | 4.55 |
| Price to Book Ratio | 2.73 |
| Enterprise Value to Revenue | 3.31 |
| Enterprise Value to EBIT | 6.28 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$353.26 M
Average shareholder expectationNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$394.77 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
371 employees
CEO: Juan Chen LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding entity, focuses globally on the research, development, production, and marketing of advanced interventional medical devices. The company provides an extensive ...